期刊论文详细信息
BMC Pulmonary Medicine | |
Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study | |
Chao-Liang Wu1  Chian-Wei Chen2  Chin-Wei Kuo3  Tang-Hsiu Huang3  Yau-Lin Tseng4  Sheng-Hsiang Lin5  | |
[1] Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan;Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan;Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan;Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan;Division of Thoracic Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan;Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan;Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan;Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; | |
关键词: Nintedanib; Krebs von den Lungen-6; Surfactant protein A; Diffusion capacity for carbon monoxide; Acute exacerbation; Mortality; | |
DOI : 10.1186/s12890-021-01530-6 | |
来源: Springer | |